{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:11:50Z","timestamp":1761765110067},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,11,7]],"date-time":"2008-11-07T00:00:00Z","timestamp":1226016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1756-8722-1-22","type":"journal-article","created":{"date-parts":[[2008,11,8]],"date-time":"2008-11-08T07:13:25Z","timestamp":1226128405000},"source":"Crossref","is-referenced-by-count":6,"title":["Treatment of stage I seminoma: is it time to change your practice?"],"prefix":"10.1186","volume":"1","author":[{"given":"Darren R","family":"Feldman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George J","family":"Bosl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,7]]},"reference":[{"key":"22_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JCO.2007.14.5920","volume":"26","author":"RT Oliver","year":"2008","unstructured":"Oliver RT, Mead GM, Fogarty PJ, Stenning SP, MRC TE19 and EORTC 30982 trial collaborators: Radiotherapy versus carboplatin for stage I seminoma: Updated analysis of the MRC\/EORTC randomized trial (ISRCTN27163214) [Abstract]. J Clin Oncol. 2008, 26: 1-10.1200\/JCO.2007.14.5920.","journal-title":"J Clin Oncol"},{"key":"22_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(05)66984-X","volume":"366","author":"RT Oliver","year":"2005","unstructured":"Oliver RT, Mason MD, Mead GM, Maase von der H, Rustin GJ, Joffe JK, de Wit R, Aass N, Graham JD, Coleman R, Kirk SJ, Stenning SP: Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet. 2005, 366: 293-300. 10.1016\/S0140-6736(05)66984-X.","journal-title":"Lancet"},{"key":"22_CR3","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.juro.2008.04.032","volume":"180","author":"DE Cooper","year":"2008","unstructured":"Cooper DE, L'Esperance JO, Christman MS, Auge BK: Testis cancer: a 20-year epidemiological review of the experience at a regional military medical facility. J Urol. 2008, 180: 577-581. 10.1016\/j.juro.2008.04.032. discussion 581-572.","journal-title":"J Urol"},{"key":"22_CR4","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMra072149","volume":"357","author":"DJ Brenner","year":"2007","unstructured":"Brenner DJ, Hall EJ: Computed tomography \u2013 an increasing source of radiation exposure. N Engl J Med. 2007, 357: 2277-2284. 10.1056\/NEJMra072149.","journal-title":"N Engl J Med"},{"key":"22_CR5","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1093\/jnci\/dji278","volume":"97","author":"LB Travis","year":"2005","unstructured":"Travis LB, Fossa SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, Hall P, Holowaty E, Andersen A, Pukkala E, Andersson M, Kaijser M, Gospodarowicz M, Joensuu T, Cohen RJ, Boice JD, Dores GM, Gilbert ES: Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst. 2005, 97: 1354-1365.","journal-title":"J Natl Cancer Inst"},{"key":"22_CR6","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1200\/JCO.2006.10.5296","volume":"25","author":"AW van den Belt-Dusebout","year":"2007","unstructured":"Belt-Dusebout van den AW, de Wit R, Gietema JA, Horenblas S, Louwman MW, Ribot JG, Hoekstra HJ, Ouwens GM, Aleman BM, van Leeuwen FE: Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol. 2007, 25: 4370-4378. 10.1200\/JCO.2006.10.5296.","journal-title":"J Clin Oncol"},{"key":"22_CR7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1200\/JCO.2005.02.7193","volume":"24","author":"AW van den Belt-Dusebout","year":"2006","unstructured":"Belt-Dusebout van den AW, Nuver J, de Wit R, Gietema JA, ten Bokkel Huinink WW, Rodrigus PT, Schimmel EC, Aleman BM, van Leeuwen FE: Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol. 2006, 24: 467-475. 10.1200\/JCO.2005.02.7193.","journal-title":"J Clin Oncol"},{"key":"22_CR8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/annonc\/mdm540","volume":"19","author":"T Powles","year":"2008","unstructured":"Powles T, Robinson D, Shamash J, Moller H, Tranter N, Oliver T: The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis. Ann Oncol. 2008, 19: 443-447. 10.1093\/annonc\/mdm540.","journal-title":"Ann Oncol"},{"key":"22_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.urolonc.2005.05.010","volume":"24","author":"I Alomary","year":"2006","unstructured":"Alomary I, Samant R, Gallant V: Treatment of stage I seminoma: a 15-year review. Urol Oncol. 2006, 24: 180-183.","journal-title":"Urol Oncol"},{"key":"22_CR10","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S0140-6736(81)91165-X","volume":"2","author":"GJ Bosl","year":"1981","unstructured":"Bosl GJ, Vogelzang NJ, Goldman A, Fraley EE, Lange PH, Levitt SH, Kennedy BJ: Impact of delay in diagnosis on clinical stage of testicular cancer. Lancet. 1981, 2: 970-973. 10.1016\/S0140-6736(81)91165-X.","journal-title":"Lancet"},{"key":"22_CR11","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1200\/JCO.1993.11.4.598","volume":"11","author":"DF Bajorin","year":"1993","unstructured":"Bajorin DF, Sarosdy MF, Pfister DG, Mazumdar M, Motzer RJ, Scher HI, Geller NL, Fair WR, Herr H, Sogani P: Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study. J Clin Oncol. 1993, 11: 598-606.","journal-title":"J Clin Oncol"},{"key":"22_CR12","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1200\/JCO.1997.15.5.1844","volume":"15","author":"A Horwich","year":"1997","unstructured":"Horwich A, Sleijfer DT, Fossa SD, Kaye SB, Oliver RT, Cullen MH, Mead GM, de Wit R, de Mulder PH, Dearnaley DP, Cook PA, Sylvester RJ, Stenning SP: Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council\/European Organization for Research and Treatment of Cancer Trial. J Clin Oncol. 1997, 15: 1844-1852.","journal-title":"J Clin Oncol"},{"key":"22_CR13","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1200\/JCO.2002.01.038","volume":"20","author":"P Warde","year":"2002","unstructured":"Warde P, Specht L, Horwich A, Oliver T, Panzarella T, Gospodarowicz M, Maase von der H: Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol. 2002, 20: 4448-4452. 10.1200\/JCO.2002.01.038.","journal-title":"J Clin Oncol"},{"key":"22_CR14","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.urology.2007.05.020","volume":"70","author":"JP Valdevenito","year":"2007","unstructured":"Valdevenito JP, Gallegos I, Fernandez C, Acevedo C, Palma R: Correlation between primary tumor pathologic features and presence of clinical metastasis at diagnosis of testicular seminoma. Urology. 2007, 70: 777-780. 10.1016\/j.urology.2007.05.020.","journal-title":"Urology"},{"key":"22_CR15","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/annonc\/mdg241","volume":"14","author":"J Aparicio","year":"2003","unstructured":"Aparicio J, Garcia del Muro X, Maroto P, Paz-Ares L, Alba E, Saenz A, Terrasa J, Barnadas A, Almenar D, Arranz JA, Sanchez M, Fernandez A, Sastre J, Carles J, Dorca J, Guma J, Yuste AL, Germa JR: Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma. Ann Oncol. 2003, 14: 867-872. 10.1093\/annonc\/mdg241.","journal-title":"Ann Oncol"},{"key":"22_CR16","doi-asserted-by":"publisher","first-page":"8717","DOI":"10.1200\/JCO.2005.01.9810","volume":"23","author":"J Aparicio","year":"2005","unstructured":"Aparicio J, Germa JR, Garcia del Muro X, Maroto P, Arranz JA, Saenz A, Barnadas A, Dorca J, Guma J, Olmos D, Bastus R, Carles J, Almenar D, Sanchez M, Paz-Ares L, Satrustegui JJ, Mellado B, Balil A, Lopez-Brea M, Sanchez A: Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study. J Clin Oncol. 2005, 23: 8717-8723. 10.1200\/JCO.2005.01.9810.","journal-title":"J Clin Oncol"}],"container-title":["Journal of Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-8722-1-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-8722-1-22\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-8722-1-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T22:04:11Z","timestamp":1548194651000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/1756-8722-1-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,7]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1186\/1756-8722-1-22","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,7]]},"article-number":"22"}}